In-class transition (iCT) from bortezomib (V)-based induction to oral ixazomib-lenalidomide-dexamethasone vs parenteral V-based therapy: comparative effectiveness in newly diagnosed multiple myeloma
Clinical Lymphoma Myeloma and Leukemia（2022）
关键词
multiple myeloma,bortezomib,in-class,ixazomib-lenalidomidedexamethasone,v-based
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要